Výsledky vyhledávání - "Harish, Ahuja"

Diversity of regulatory T cells in various immuno-physiological conditions

Autor: Harish Ahuja, M Ganapathi Bhat, R. D. Lele, Pooja Shahapurkar

Publikováno v: International Journal of Research in Medical Sciences. 8:3988

Background: Regulatory T cells (Tregs) play an active role in abrogating immune responses during microbial infections and are thus essential to maintain immune homeostasis and self-tolerance. Aberrant expression of Tregs can lead to spectrum of manif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db0da019c9146fb4ffb95dc312599517
https://doi.org/10.18203/2320-6012.ijrms20204891

Zobrazit plný text záznamu

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study

Autor: Arielle Baim, Jules H. Blank, Sandeep Saha, Harish Ahuja, Anne M. Traynor, Timothy S. Fenske, Ryan J. Mattison, Tim Wassenaar, Kyung Mann Kim, Namrata Shah, Patrick Mansky, Rubina Qamar, Chong Zhang, John P. Farnen, Brad S. Kahl, Adedayo A. Onitilo

Publikováno v: Cancer. 121:3465-3471

BACKGROUND Proteasome inhibitors and mammalian target of rapamycin inhibitors each have activity in various B-cell malignancies and affect distinct cellular pathways. Their combination has demonstrated synergy in vitro and in mouse models. METHODS Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07fee0f189635ba243ef98770c1b74b4
https://doi.org/10.1002/cncr.29502

Zobrazit plný text záznamu

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study

Autor: Peter H. Johnson, Jules H. Blank, Tien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Anne M. Traynor, Harish Ahuja, Jill M. Kolesar, Mary E. Wims, Michael S. Huie, Emily Robinson, Hilary R. Hernan, Ron J. Kirschling, Kurt R. Oettel, Martha M. Larson

Publikováno v: Investigational New Drugs. 32:195-199

Introduction The primary objective of this phase II trial was to evaluate the efficacy and tolerability of vorinostat and bortezomib as third-line therapy in advanced non-small cell lung cancer (NSCLC) patients. Methods Eligibility criteria included

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29eab44cb18d05d6442bf3c55f86f82
https://doi.org/10.1007/s10637-013-9980-5

Zobrazit plný text záznamu

Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer

Autor: Mary Jane Staab, Harish Ahuja, Jules H. Blank, Rebecca Marnocha, Alcee Jumonville, Dottie Horvath, Dona Alberti, Jens C. Eickhoff, Jane Straus, Michael Eastman, Michael Glode, Douglas G. McNeel, Glenn Liu, Steven Attia, George Wilding, Daniel H. Shevrin

Publikováno v: Clinical Cancer Research. 14:2437-2443

Purpose: Docetaxel is standard of care for androgen-independent prostate cancer (AIPC). Doxercalciferol (1α-hydroxyvitamin D2) had modest activity in phase I/II trials. Preclinical data support combining vitamin D analogues with docetaxel to treat A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8e0b04b2602d7cf4236f21702abe3e
https://doi.org/10.1158/1078-0432.ccr-07-4274

Zobrazit plný text záznamu

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study

Autor: Timothy S, Fenske, Namrata M, Shah, Kyung Mann, Kim, Sandeep, Saha, Chong, Zhang, Arielle E, Baim, John P, Farnen, Adedayo A, Onitilo, Jules H, Blank, Harish, Ahuja, Tim, Wassenaar, Rubina, Qamar, Patrick, Mansky, Anne M, Traynor, Ryan J, Mattison, Brad S, Kahl

Publikováno v: Cancer. 121(19)

Proteasome inhibitors and mammalian target of rapamycin inhibitors each have activity in various B-cell malignancies and affect distinct cellular pathways. Their combination has demonstrated synergy in vitro and in mouse models.The authors conducted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::59488b09a25835caf47198bef605c525
https://pubmed.ncbi.nlm.nih.gov/26079295

Zobrazit plný text záznamu

Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer

Autor: Tien Hoang, Joseph Merchant, Martha M. Larson, Joan H. Schiller, KyungMann Kim, Thomas A. Hensing, Fredrico A. Sanchez, James McGovern, Anne M. Traynor, Harish Ahuja, Kurt R. Oettel

Publikováno v: Journal of Thoracic Oncology. 1(3):218-225

Background The study was designed to evaluate the safety and efficacy of exisulind, a selective apoptotic antineoplastic drug, in combination with gemcitabine as second-line therapy in patients with progressing advanced non–small cell lung cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c21dd56b8e3ce456704a8c4832a4aa4

Zobrazit plný text záznamu

Emplacement kinematics of nepheline syenites from the Terrane Boundary Shear Zone of the Eastern Ghats Mobile Belt, west of Khariar, NW Orissa: Evidence from meso- and microstructures

Autor: Harish Ahuja, Tapas Kumar Biswal, Himansu Sekhar Sahu

Publikováno v: Journal of Earth System Science. 113:785-793

Nepheline syenite plutons emplaced within the Terrane Boundary Shear Zone of the Eastern Ghats Mobile Belt west of Khariar in northwestern Orissa are marked by a well-developed magmatic fabric including magmatic foliation, mineral lineations, folds a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a75c9cdbc1559e1ec4a1976347db4e8b
https://doi.org/10.1007/bf02704037

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání